Cover
Cover | Dec. 15, 2021 |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Dec. 15, 2021 |
Entity File Number | 001-40410 |
Entity Registrant Name | ORION BIOTECH OPPORTUNITIES CORP |
Entity Central Index Key | 0001847416 |
Entity Tax Identification Number | 98-1583924 |
Entity Incorporation, State or Country Code | E9 |
Entity Address, Address Line One | 645 Fifth Avenue |
Entity Address, Address Line Two | 21st Floor |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10022 |
City Area Code | (212) |
Local Phone Number | 303-1650 |
Written Communications | true |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and one-fifth of one redeemable warrant | |
Title of 12(b) Security | Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and one-fifth of one redeemable warrant |
Trading Symbol | ORIAU |
Security Exchange Name | NASDAQ |
Class A ordinary shares included as part of the Units | |
Title of 12(b) Security | Class A ordinary shares included as part of the Units |
Trading Symbol | ORIA |
Security Exchange Name | NASDAQ |
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 | |
Title of 12(b) Security | Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 |
Trading Symbol | ORIAQ |
Security Exchange Name | NASDAQ |